when did semaglutide come out Semaglutide Weight Loss Approval Timeline

Weight loss was initially observed as a side effect of GLP-1 medications in clinical trials testing the drugs for type 2 diabetes

Aside from the advantage of having higher appeal to people who are squeamish with needles, oral formulations remove the need for cold chain storage for injectable forms of GLP1R/GIPR/GR agonists , which otherwise must be stored at cold temperatures if not provided in a dry (Tablet/pill) form

Youll also want to consider which form of supplement you prefer, such as a liquid, capsule, or gummy, and your preferred dose

Another review listed a study that followed 1022 patients with breast cancer, 389 of whom took a GLP-1R agonist for up to 12 months, which resulted in up to 3.1% weight loss

Retatrutide is currently in Phase 3 clinical trials and is not FDA approved yet

Do we need millions and millions of people to say, "Hey, this therapy works for people with that"